Clinical Trial Update: A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1) [NA]

View source ↗

Summary

A terminated clinical trial evaluating INFUSE Bone Graft (BMP-2) for tibial pseudarthrosis in patients with Neurofibromatosis Type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Pseudarthrosis of the Tibia
• Neurofibromatosis Type

Drugs mentioned

• INFUSE Bone Graft (BMP-2) (bone morphogenetic protein-2)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: NF1, Congenital Pseudarthrosis of Tibia | NA | Status: TERMINATED | Results posted: 2021-10-27